- Home
- FOSL vs SRZN Comparison
FOSL vs SRZN Comparison
Compare FOSL & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FOSL
- SRZN
- Stock Information
- Founded
- FOSL 1984
- SRZN 2015
- Country
- FOSL United States
- SRZN United States
- Employees
- FOSL N/A
- SRZN N/A
- Industry
- FOSL Consumer Specialties
- SRZN Medicinal Chemicals and Botanical Products
- Sector
- FOSL Consumer Discretionary
- SRZN Health Care
- Exchange
- FOSL Nasdaq
- SRZN Nasdaq
- Market Cap
- FOSL 100.0M
- SRZN 65.5M
- IPO Year
- FOSL 1993
- SRZN N/A
- Fundamental
- Price
- FOSL $1.50
- SRZN $8.13
- Analyst Decision
- FOSL
- SRZN Strong Buy
- Analyst Count
- FOSL 0
- SRZN 2
- Target Price
- FOSL N/A
- SRZN $38.50
- AVG Volume (30 Days)
- FOSL 402.4K
- SRZN 12.6K
- Earning Date
- FOSL 05-14-2025
- SRZN 05-09-2025
- Dividend Yield
- FOSL N/A
- SRZN N/A
- EPS Growth
- FOSL N/A
- SRZN N/A
- EPS
- FOSL N/A
- SRZN N/A
- Revenue
- FOSL $1,123,399,000.00
- SRZN $11,638,000.00
- Revenue This Year
- FOSL N/A
- SRZN N/A
- Revenue Next Year
- FOSL N/A
- SRZN N/A
- P/E Ratio
- FOSL N/A
- SRZN N/A
- Revenue Growth
- FOSL N/A
- SRZN N/A
- 52 Week Low
- FOSL $0.86
- SRZN $5.90
- 52 Week High
- FOSL $2.61
- SRZN $18.17
- Technical
- Relative Strength Index (RSI)
- FOSL 58.14
- SRZN 46.15
- Support Level
- FOSL $1.42
- SRZN $7.60
- Resistance Level
- FOSL $1.63
- SRZN $8.70
- Average True Range (ATR)
- FOSL 0.13
- SRZN 0.84
- MACD
- FOSL -0.01
- SRZN 0.15
- Stochastic Oscillator
- FOSL 54.90
- SRZN 79.79
About FOSL Fossil Group Inc.
Fossil Group Inc is a design, innovation and distribution company in consumer fashion accessories. The products include traditional watches, smartwatches, jewelry, handbags, small leather goods, belts and sunglasses. The reportable segments are comprised of 1) Americas segment includes sales in Canada, Latin America and the United States. 2) Europe segment includes sales in European countries, the Middle East and Africa. 3) Asia segment includes sales in Australia, China, India, Indonesia, Japan, Malaysia, New Zealand, Singapore, South Korea and Thailand. Each reportable operating segment includes sales to wholesale and distributor customers, and sales through Company-owned retail stores and e-commerce activities based on the location of the selling entity.
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).